Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 80 Lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP, Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity


Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product. The impurity detected in the finished drug product is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification. To date, Aurobindo Pharma USA, Inc. has not received any reports of adverse events related to this recall. (US Food Recalls) More More

Similar stories

Aurobindo Pharma Adds to Nationwide Valsartan Blood Pressure Medication Recall - Diagnostic and Interventional Cardiology

Aurobindo Pharma Adds to Nationwide Valsartan Blood Pressure Medication Recall  Diagnostic and Interventional Cardiology

January 10, 2019 — Aurobindo Pharma USA Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP ...

Posted on 10 January 2019 | 3:00 am | Google News

Aurobindo Recalls 80 Lots of Valsartan Tablets - Pharmacy Times

Aurobindo Recalls 80 Lots of Valsartan Tablets  Pharmacy Times

Aurobindo Pharma USA is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the ...

Posted on 1 January 2019 | 3:00 am | Google News

Aurobindo Pharma USA recalls 80 lots of blood pressure drug from US - Business Standard

Aurobindo Pharma USA recalls 80 lots of blood pressure drug from US  Business Standard

Aurobindo Pharma USA Inc is recalling 80 lots of tablets used for treatment of high blood pressure and heart failure from the American market due to presence of ...

Posted on 1 January 2019 | 3:00 am | Google News

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 80 Lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP, Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity - US Recall News

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 80 Lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP, Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity  US Recall News

65862-737-30 Amlodipine and Valsartan Tablets USP5mg/160mg 30 VESA17013-A 10/2019 65862-737-30 Amlodipine and Valsartan Tablets USP5mg/160mg ...

Posted on 31 December 2018 | 3:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info